突触:在前性痴呆症和肌性侧面硬化症中发生突触前融合
Emma L Clayton1,2, Laura Huggon1,2, Michael A Cousin3,4,5
1UK Dementia Research Institute at King's College London, London SE5 9RT, UK.
Brain : a journal of neurology
|March 7, 2024
概括
前性痴呆症和骨髓缩性侧面硬化症共享早期的前突触功能障碍,称为突触病. 这篇综述强调了前突触突触作为一个融合机制,对于开发有效治疗神经退行性疾病至关重要.
科学领域:
- 神经科学是一个神经科学.
- 神经退行性疾病 神经退行性疾病
- 分子生物学分子生物学
背景情况:
- 前性痴呆症 (FTD) 和肌性侧面硬化症 (ALS) 是普遍存在的神经退行性疾病,具有共同的遗传和病理特征.
- 目前,FTD或ALS没有疾病修饰治疗方法,这强调了需要识别治疗干预的早期病理事件的必要性.
研究的目的:
- 探讨突触病,特别是突触前功能障碍,代表FTD和ALS中早期和融合的病理机制的假设.
- 审查最近的发现,将FTD和ALS中的遗传突变与突触前功能障碍联系起来,并确定潜在的治疗点.
主要方法:
- 关于FTD,ALS,突触病和突触前功能的最新出版物的文献综述.
- 对研究FTD和ALS的基因突变及其对突触前生理学影响的研究进行分析.
- 综合证据支持突触前突触症作为一个常见的途径.
主要成果:
- 与FTD和ALS相关的突变经常表现为通过突触前功能障碍特征的突触病.
- 突触损失和突触前神经传递受损是这些神经退行性疾病的早期特征.
- 预突触突触症作为FTD和ALS的家族和零星形式之间的融合机制出现.
结论:
- 预突触突触病是前性痴呆症和肌缩性侧面硬化症中的早期,共享的病理事件.
- 针对前突触机制为FTD和ALS提供了一个有前途的治疗策略.
- 对前突触功能障碍的进一步研究对于开发这些破坏性神经退行性疾病的有效治疗方法至关重要.
相关概念视频
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Parkinson's Disease: Overview
544
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
544


